SCIENION [ˈsaɪnɪən] is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. We provide our customers with an integrated product portfolio facilitating and improving multiplex analysis, high throughput screening and high throughput production of microarrays in the genomics and proteomics fields – from early research to manufacturing.
We provide our customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions, with high quality products and services, to facilitate confidence and efficiency in all aspects of their applications.
Based on SCIENION’s long standing expertise and proprietary platform technologies our product portfolio comprises hardware, consumables and services.
SCIENION’s proprietary microarray and liquid handling technologies were awarded twice with the “Innovationspreis Berlin-Brandenburg”. The annual prize is jointly awarded by the German Federal States of Berlin and Brandenburg for product and process innovations and innovative technology services.
Founded in 2000 in Berlin as a spin-off of the Max-Planck-Institute for Molecular Genetics, the privately held company today operates from two sites, Dortmund and Berlin.
In December 2011 SCIENION founded an US subsidiary in Princeton, New Jersey to start selling its products and services directly into the North American market.
In October 2016 SCIENION opens French subsidiary Cellenion with focus on controlled cell dispensing technologies.